NORWALK, Conn., March 19, 2015 /PRNewswire/ -- UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers, is featuring special coverage of multiple sclerosis in observance of MS Awareness Month.
MS affects 2.5 million persons worldwide, including more than 400,000 Americans, and is the most common disabling neurologic disease of young adults. There is no cure or clear way to prevent MS, but researchers are continually seeking the causes and more therapeutic options.
Among the highlights of MS coverage at Neurology Times are these recent research findings:
- 3 New Things About MS. Coffee intake may protect against MS, women with MS may consume lower amounts of antioxidant and anti-inflammatory nutrients, and identifying MS' pathological progression may lead to new treatment options.
- Double Duty: Blood Pressure Drug Also Eases MS: Guanabenz, an FDA-approved drug for high blood pressure, prevents myelin loss and alleviates clinical symptoms of MS in mice. The findings point to promising avenues for new therapeutics for MS in humans.
- Stem Cells Top Drug Therapy in Severe MS: Intense immunosuppression followed by autologous hematopoietic stem cell transplantation may be superior to current treatment for patients with severe MS that is not responding well to standard treatments.
- Stratifying PML Risk in Multiple Sclerosis: These study findings will help clinicians faced with the difficult choice about how to manage patients with MS on Tysabri who become positive for JC virus antibodies or are already positive for these antibodies.
About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections. Headquartered in New York, UBM Connect brings together UBM's healthcare business, UBM Medica US; UBM Canon's advanced design and manufacturing event, online and print brands; UBM Connect New York's catering, cruise shipping, customer management, and fine, specialty and custom chemical communities; and UBM Mexico's concrete show. For more information, visit www.UBMMedicaUS.com.
About UBM plc
UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.
For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.
CONTACT: Jason J. Golden, Content Marketing Manager, 203-523-7040
SOURCE UBM Medica US